Boston Therapeutics Inc Press Releases

BTHE 
$0.305
*  
0.055
22%
Get BTHE Alerts
*Delayed - data as of Oct. 21, 2014  -  Find a broker to begin trading BTHE now


Community Rating:
View:    BTHE After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Boston Therapeutics Reports Topline U.S.-Based Phase IIb Study Results of BTI-320 in Patients With Type 2 Diabetes
10/9/2014 8:38:00 AM - Market Wire


Boston Therapeutics Appoints David S.H. Bell, MB, FACP, FACE to Its Medical Advisory Board
10/8/2014 7:00:00 AM - Market Wire


Boston Therapeutics Files Patent Application for Novel Therapeutic Uses of BTI-320
10/7/2014 7:00:00 AM - Market Wire


Boston Therapeutics Appoints Jan Brinkman, M.D., Ph.D. and Alan M. Hoberman, Ph.D. to Board of Directors
10/1/2014 1:46:00 PM - Market Wire


RR Media Selected to Deliver Arsenal FC Media
9/29/2014 7:00:00 AM - Market Wire


Benchworks Collaborates With Boston Therapeutics to Market sugardown(R)
9/29/2014 7:00:00 AM - Market Wire


Boston Therapeutics Appoints Meng Hee Tan, M.D. to Consulting Medical Director
9/23/2014 7:00:00 AM - Market Wire


Boston Therapeutics Signs Clinical Trial Agreement With Prestigious Joslin Diabetes Center for Phase III Study of BTI-320
9/22/2014 7:00:00 AM - Market Wire


Boston Therapeutics to Present Findings of BTI-320 as Therapy for Glycemic Control at 50th Annual Meeting of European Association for the Study of Diabetes
9/16/2014 7:20:00 AM - Market Wire


Boston Therapeutics to Present at National Investment Banking Conference on September 16, 2014
9/15/2014 8:27:00 AM - Market Wire


Boston Therapeutics to Present at Rodman & Renshaw Annual Global Investment Conference on September 10, 2014
9/5/2014 8:36:00 AM - Market Wire


Boston Therapeutics Completes Enrollment of Patients With Type 2 Diabetes in Phase IIb Study on BTI-320 in the U.S.
8/20/2014 8:11:00 AM - Market Wire


Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
8/18/2014 7:25:00 AM - Market Wire


Boston Therapeutics Reports Corporate Update and Financial Results for the Second Quarter Ended June 30, 2014
8/8/2014 10:55:00 AM - Market Wire


Boston Therapeutics Expands Medical Advisory Board
8/5/2014 7:00:00 AM - Market Wire


Boston Therapeutics to Sponsor Symposium at American Chemical Society's Fall National Meeting in San Francisco
7/30/2014 6:30:00 AM - Market Wire


Boston Therapeutics Appoints Zbigniew J. Witczak, Ph.D., to Its Scientific Advisory Board
7/29/2014 6:30:00 AM - Market Wire